<DOC>
	<DOCNO>NCT00129467</DOCNO>
	<brief_summary>The purpose study determine whether methylphenidate effective treatment depression document safety tolerability methylphenidate combination Selective Serotonin Reuptake Inhibitor ( SSRI ) SSRI treat , terminally ill , hospice palliative care cancer patient . The investigator hypothesize depressed hospice palliative care patient likely 50 % reduction score clinical measure depression treatment Methylphenidate plus SSRI compare patient take placebo plus SSRI .</brief_summary>
	<brief_title>Methylphenidate Depressed Cancer Patients Receiving Palliative Care</brief_title>
	<detailed_description>Background : Major depressive disorder diagnose 5 % 26 % terminally ill patient . This disorder cause suffer , associate suicidality , increase pain , increase caregiver burden caregiver depression . Treatment depression cancer patient hospice palliative care complicate shorten life expectancy . Currently-approved antidepressant take several week effective . Methylphenidate report case series small randomized trial patient without cancer rapidly effective treatment depression medically ill patient . There randomize control trial test agent terminally ill cancer patient . Objectives : ( 1 ) To determine effectiveness safety methylphenidate depression treatment cancer patient receive hospice palliative care , ( 2 ) explore whether successful treatment depression associate improved quality life , ( 3 ) explore whether effective treatment depression influence caregiver depression caregiver burden . Methods : We conduct 18-day randomize , double-blind , fixed-dose ( 10 mg bid ) , placebo-controlled clinical trial methylphenidate depression eligible veteran non-veteran cancer patient advance cancer follow setting : inpatient outpatient hospice , inpatient outpatient palliative care , inpatient outpatient cancer clinic . We determine whether improvement depression mediate decreased pain document safety tolerability methylphenidate patient . We explore whether improvement depression result improve quality life patient , decrease caregiver depression burden . Eligible patient answer yes question `` sad depressed '' invite participate . They complete measure depression [ Structured Clinical Interview Diagnosis ( SCID ) , Montgomery-Asberg Depression Rating Scale ( MADRS ) primary outcome , Hospital Anxiety Depression Scale ( HADS ) secondary outcome ] , quality life , pain , cognition baseline . MADRS score must great 19 SCID positive depression study entry . Subjects randomize either methylphenidate plus SSRI , placebo plus SSRI . Subjects may continue previously prescribe SSRI , prescribe citalopram untreated . Participants evaluate measure baseline day 3 , 6 , 12 18 study . In open label portion study , methylphenidate-treated patient whose depression improve follow 2 month . Cox proportional hazard analysis use analyze primary outcome . An estimated 104 subject enter five year . Caregivers complete measure depression caregiver burden day 0 18 .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Inclusion : Either enrol OHSU radiology/oncology clinic VA palliative care , live within 120 mile Portland VAMC . Lifelimiting disease type solid blood cancer . Eighteen year age older . Life expectancy 1 year less reflected hospice admission palliative care status . Although exact life expectancy predict , actively die patient estimate life expectancy &lt; 10 day unlikely enrol . Diagnosis major depression disorder determine Structured Clinical Interview Diagnosis ( SCID ) . Significant depressive cognitive symptomatology determine MADRS great 19 . Currently take SSRI still depress enough meet eligibility criterion take SSRI depress enough start SSRI . Willing able give inform consent participate study demonstrate MacArthur Competence Assessment Tool clinical research . Speaks/understands English . For patient home selfadminister medication , caregiver assist administer medication . Exclusion : Dementia Delirium determine Short Portable Mental Status Questionnaire ( SPMSQ ) score less 7 . Diagnosis delirium determine Confusional Assessment Method ( CAM ) . Any follow Brief Psychiatric Rating Scale ( BPRS ) item rat 4 , elate mood , suspiciousness , hallucination , excitement , distractibility motor hyperactivity . Severe insomnia . Severe anxiety . Significant suicidal ideation . History current mental disorder depressive symptom occur , psychostimulants contraindicate ( schizophrenia bipolar disorder base history ; active psychotic symptom select BPRS item ) . History stimulant abuse active , severe substance abuse . Contraindications methylphenidate SSRI include significant cardiac arrhythmia ; uncontrolled , severe hypertension ; moderatesevere angina ; seizure disorder ; severe COPD ; use medication Levodopa , monoamine oxidase inhibitor , lithium ; diagnosis narrowangle glaucoma ; history SSRIinduced hyponatremia , . Physical symptom include increase blood pressure ( DBP great 115 , SBP great 180 ) , pulse great 120 , irregular pulse , chest pain consistent angina . Treatment depression nonSSRI antidepressant include Bupropion Venlafaxine protocol . Known serum creatinine &gt; 3.0 , severe liver disease reflect jaundice hepatic encephalopathy . Unable swallow pill , however patient gastrostomy tube feed tube place study medicine may administer route . Pills may pour food . Receiving hospice care skilled nursing facility .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Depression</keyword>
	<keyword>Hospice Care</keyword>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Central Nervous System Stimulant</keyword>
	<keyword>Pain</keyword>
	<keyword>Caregiver Burden</keyword>
	<keyword>Cancer</keyword>
</DOC>